Journal article icon

Journal article

Strong bipartisan support for controlled psilocybin use as treatment or enhancement in a representative sample of US Americans: need for caution in public policy persists

Abstract:

The psychedelic psilocybin has shown promise both as treatment for psychiatric conditions and as a means of improving well-being in healthy individuals. In some jurisdictions (e.g., Oregon, USA), psilocybin use for both purposes is or will soon be allowed and yet, public attitudes toward this shift are understudied. We asked a nationally representative sample of 795 US Americans to evaluate the moral status of psilocybin use in an appropriately licensed setting for either treatment of a psych...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1080/21507740.2024.2303154

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
HUMS
Department:
Philosophy Faculty
Role:
Author
Publisher:
Taylor & Francis
Journal:
AJOB Neuroscience More from this journal
Volume:
15
Issue:
2
Pages:
82-89
Publication date:
2024-02-05
Acceptance date:
2023-11-20
DOI:
EISSN:
2150-7759
ISSN:
2150-7740
Language:
English
Keywords:
Pubs id:
1570263
Local pid:
pubs:1570263
Deposit date:
2023-11-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP